Houston Methodist Research Institute scientists recently made a surprise discovery that could potentially change the way cholesterol is treated.
The accidental breakthrough began as an innocuous task.
Bingqing Xu, a third-year medical student from China, joined a research program led by Henry Pownall, Ph.D., professor of bioenergetics at the Houston Methodist Research Institute. One of the program’s goals was to assist Xu in publishing a paper. Since no one had fully validated the current model of cholesterol transport from the arteries to the liver, Pownall decided that it would be an appropriate topic for Xu to explore. Little did they know that her research would lead them to new evidence that challenges a decades-long assumption of how the body processes and eliminates cholesterol.
“It was a very benign proposal. It was going to be easy, nothing controversial,” Pownall said, “but it turned out that the hypothesis was not valid. She found something totally opposite.”
For four decades, the medical community has believed that cholesterol travels from the arteries, becomes absorbed by a particle and remains in the blood for three to five days before being excreted from the body by the liver. However, Pownall and his team showed that a nascent form of cholesterol known as free cholesterol—an early form of high-density lipoprotein (HDL) cholesterol, often referred to as “good” cholesterol—bypasses this process and instead travels directly from the particle to the liver within two to three minutes, a thousand times faster than scientists had previously believed.
“We’re not erasing 40 years of history, but we’re definitely updating and bringing to light mechanisms that other people had not previously researched because they just took for granted that there was only one pathway,” said Corina Rosales, Ph.D., an assistant research professor of bioenergetics at Houston Methodist Research Institute. “We’re trying to find those correct pathways and not just follow everybody else. It’d then be like the blind leading the blind, in a sense.”
Many clinical trials use drugs to inhibit the transfer of cholesteryl ester, a mature form of cholesterol found in the body. The drugs are designed to reduce the risk of atherosclerosis, a precursor for heart attack and stroke caused by the buildup of cholesterol in the arteries. However, a number of the drugs failed to yield any meaningful clinical improvement or led to death, despite increasing “good” cholesterol levels.
“There were at least three different forms of inhibitors that have been duds because they were focused on the wrong aspect of HDL biology,” said Baiba Gillard, Ph.D., an assistant research professor of bioenergetics at the Houston Methodist Research Institute. “We’re hoping our refocus will be more productive.”
Equipped with the new understanding that free cholesterol is eliminated from the body by the liver much faster than cholesteryl ester, the team said they believe their findings will encourage scientists to take a closer look at how HDL cholesterol contributes to cardiovascular disease and how to increase HDL cholesterol levels in ways that are beneficial to the heart, thus opening the door to more effective therapies.
“The most important thing is that we really need to elucidate all the proper mechanisms and pathways for cholesterol and other lipids in order to develop good therapeutics,” Rosales said. “If you don’t know the pathways or if you don’t know how they’re metabolized, then you can’t really develop a good therapeutic agent to treat … lipid disorders, atherosclerosis or conditions like that.”
The team plans to continue their research in partnership with the Houston Methodist cardiology department to test patients’ plasma and determine how “good” cholesterol has affected their heart health.
#TalkTuesday: Avocados are one of the best sources of vitamin E. They help to reduce blood pressure and lower cholesterol levels. And they’re delicious, too! Have you added this #superfood into your diet?
.@ColonCancerDoc on new #colorectalcancer surveillance study: “These findings differ from historical data and argue to reconsider current guideline recommendations, in the U.S.” https://t.co/F844eC5ya8 #CRCSM #endcancer
Playing #guitar during #braintumor surgery helps Dr. Sujit Prabhu preserve survivor Robert Alvarez’s brain function: “Everything worked like a symphony.” #BTSM #endcancer https://t.co/kELJrAzSbz
MD Anderson Cancer CenterMDAnderson
“I knew I had pancreatic cancer,” Jane Mooney recalls. “But I chose not to know any other details, because the only way for me to remain optimistic was to keep my life very simple. I had to concentrate on the task at hand.” #endcancer
Why #prostatecancer survivor Andy Moriarty advocates for men to get annual physical and cancer screenings: https://t.co/IyuGHSWuw2 #CancerMoonshot #endcancer https://t.co/SKp1Tz4CDz
Mark your calendars now for a Geriatrics for Primary Care Providers course on June 23. Register here: https://t.co/QwSaH6KVwL https://t.co/sK8kRsRKDA
Baylor College of MedicineBaylorCollegeOfMedicine
Bumping up your weekly exercise over as little as six years could lead to a decrease in heart failure risk.
Specialty court helps Veterans get back on track https://t.co/qYxnqZRAQE via @GainesvilleSun
Two-hundred and twenty-seven McGovern Medical School students marched across the stage to receive their degrees during the school's 45th commencement ceremony on May 18. Congratulations, graduates! #UTHealth18 #ManyFacesOfUTHealth
Known for providing the highest level of care for adults & children with critical injuries, the Red Duke Trauma Institute at Memorial Hermann-Texas Medical Center is one of the busiest Level I trauma centers in the nation. Watch part two: https://t.co/K9PoJyjeGZ. #EMSWeek #TeamMH https://t.co/1WwG3Qh0D3
Researchers have synthesized and isolated plasmonic magnesium nanoparticles that show all the promise of their gold, silver and aluminum cousins with none of the drawbacks. https://t.co/vlCSeReYKN https://t.co/rYDoL5aetL
Fargo VA selected for ‘Whole Health’ initiative https://t.co/RGFuTDArDq via @inforum
Today’s #VeteranOfTheDay is @USArmy Veteran Elvis Arthur Mason. https://t.co/ij3B2SLLlk
U.S. Department of Veterans AffairsVeteransAffairs
Today’s #VeteranOfTheDay is Army Veteran Elvis Arthur Mason. Arthur served from 1942 to 1946 and 1950 to 1952. Elvis was born in October 1921 in Elberfeld, Indiana. He moved to Oakland City, Indiana and was drafted into the Army at the age of 20. Elvis completed basic training at Camp Swift, Texas and was assigned to an infantry regiment. He also completed swamp training, desert training and mountain training in Louisiana, California and West Virginia, respectively. Elvis’s unit was deployed to Europe and landed in England shortly after D-Day. Elvis traveled to France and volunteered to drive gasoline to other allied camps. His unit engaged in combat for 100 consecutive days and moved through France, Germany, Luxembourg, Belgium and Holland to push the German army back. Elvis took over as platoon leader during this campaign and credited the platoon’s camaraderie for helping the soldiers get through the difficult time. Elvis briefly remained in Europe after Germany surrendered and participated in the liberation of a poorly maintained camp of German citizens. He then returned to the United States and was preparing to travel to Japan when the Japanese surrendered in 1945. Elvis continued to serve at Camp Shelby, Mississippi and Camp Butler, North Carolina before he was honorably discharged in December, 1945. He joined the Army reserves and was called to join the Korean War in 1950. He reported to Fort Leonard Wood, Missouri in October and served in Japan and Korea, where he helped to build roads and airstrips for artillery planes. Elvis was awarded the Purple Heart and a Bronze Star. He passed away on July 14, 2012 at the age of 90. We honor his service.
Looking for a gift for your graduate to remember his or her time at Baylor College of Medicine? Check out our team shop for shirts, hats, cups, and so much more! https://t.co/QQw2ZfLPHk https://t.co/9wxEsAZxOJ